Dr. Matteo Trucco is the Director of the Children’s Cancer Innovative Therapy Program and a practicing Pediatric Oncologist at the Cleveland Clinic and Case Comprehensive Cancer Center. He joined the Cleveland Clinic in November 2019 and develops clinical trials both locally and in collaboration with national consortia and pharmaceutical companies to identify new and less toxic treatments for children with cancer.
Dr. Trucco completed his undergraduate training at the University of Pennsylvania with a B.A. in Biology and Philosophy of Science. He graduated at the top of his class from Temple University School of Medicine where he was inducted in the Alpha Omega Alpha Honor Medical Society during his Junior year and received numerous awards including the Benjamin and Mary Siddons Measey Foundation Scholarship, and the Waldo E. Nelson M.D. Pediatric Award. He then completed his Pediatrics Internship and Residency at Rainbow Babies and Children’s Hospital/ Case Western Reserve University where he was again acknowledged with several awards and commendations for his patient care.
Dr. Trucco’s Pediatric Hematology/Oncology training was completed at Johns Hopkins University and the National Cancer Institute. Upon completing his fellowship training, Dr. Trucco was recruited to Texas Children’s Hospital and awarded a coveted position in the K12 Faculty Fellowship in Pediatric Oncology Clinical Research. During his four years as faculty at Texas Children’s Hospital, Dr. Trucco obtained a Certificate of Added Qualification in Clinical Investigations and was an active member of the Solid Tumor Team, Bone Sarcoma Team and Phase 1 Clinical Trial Team, led clinical trials and studied the altered metabolism of pediatric bone tumors and how to use these alterations to develop new therapies for these cancers.
Dr. Matteo Trucco was recruited to the Sylvester Comprehensive Cancer Center at University of Miami-Miller School of Medicine in 2016 to direct the Early Phase Pediatric Clinical Research Program where he greatly expanded the number of clinical trials available to pediatric cancer patients in Southern Florida and first became involved with the SebastianStrong Foundation and helped establish its Medical Advisory Board. He continues to be involved with SebastianStrong working to achieve their goal of better, less toxic treatments for children with cancer.